← Open Payments lookup

THEODORE MATEJKA: Open Payments

NPI 1396742490 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,604 in 50 payments from 17 companies in 2025. Trend: 2023 $2,551 · 2024 $3,298 · 2025 $2,604

Food & beverage: $2,597Education: $7
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$396
Vanda Pharmaceuticals Inc.8$335
Alexion Pharmaceuticals, Inc.2$267
Gilead Sciences, Inc.2$259
Otsuka America Pharmaceutical, Inc.5$202
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$151
Edwards Lifesciences Corporation1$139
Teva Pharmaceuticals USA, Inc.3$136
Apellis Pharmaceuticals, Inc.1$120
SANOFI-AVENTIS U.S. LLC1$101

Products named: INGREZZA, FANAPT, STRENSIQ, CAPLYTA, SAPIEN 3 Ultra RESILIA, AUSTEDO XR, Livdelzi, Epclusa.

Industry payments across FL — which companies pay providers there.